Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH

Published:2018-06-05 Issue:7 Volume:16 Page:1437-1441
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Ragni M. V.¹,Croteau S. E.²,Morfini M.³,Cnossen M. H.⁴,Iorio A.⁵,

Affiliation:

1. Department of Medicine; Division Hematology Oncology; University of Pittsburgh; Pittsburgh PA USA

2. Division of Hematology-Oncology; Boston Children's Hospital; Harvard Medical School; Boston MA USA

3. Italian Association of Haemophilia Centers; Florence Italy

4. Department of Pediatric Hematology; Erasmus University Medical Center-Sophia Children's Hospital; Rotterdam the Netherlands

5. Department of Health Research, Methods, Evidence and Impact, and Department of Medicine; McMaster University; Hamilton ON Canada

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.14153/fullpdf

Reference23 articles.

1. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A;Collins;J Thromb Haemost,2009

2. Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices. individualizing prophylaxis in patients with haemophilia A;Walsh;Haemophilia,2009

3. Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis;Valentino;Haemophilia,2016

4. Target plasma factor levels for personzlied treatment in haemophilia: a Delphi consensus statement;Iorio;Haemophilia,2017

5. Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults, the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring;Björkman;J Thromb Haemost,2010

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B;Research and Practice in Thrombosis and Haemostasis;2024-03

2. The influence of dead space in blood sampling needle on FVIII level and pharmacokinetic profiles in children with hemophilia;Hematology;2024-02-12

3. Shifting Paradigms and Arising Concerns in Severe Hemophilia A Treatment;Seminars in Thrombosis and Hemostasis;2024-01-15

4. Development and internal validation of a clinical prediction model for individualized dosing of BAY 81-8973, A full-length recombinant factor VIII, in pediatric patients with haemophilia A;Thrombosis Research;2023-12

5. The road to implementation of pharmacokinetic-guided dosing of factor replacement therapy in hemophilia and allied bleeding disorders. Identifying knowledge gaps by mapping barriers and facilitators;Blood Reviews;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3